Eccogene is focused on building a pipeline of best-in-class small molecule therapeutics for chronic cardiometabolic and inflammatory conditions with the goal of improving care and expanding access to cost effective medicines for millions of patients worldwide. Since our inception, our team has been dedicated to discovering safer and more effective oral therapies that may be used alone or synergistically with a GLP-1 receptor agonist to treat conditions beyond obesity.
Among our core strengths is our team -- comprised of individuals with world-class expertise in translational research and small molecule discovery -- as well as our deep understanding of diabetes, weight loss and cardiometabolic disease pathways. Our oral small molecule GLP-1 receptor agonist, ECC5004, is a potentially best-in-class asset, which we licensed to AstraZeneca. To expand on the opportunity in cardiometabolic disease, we are also advancing clinical programs targeting THR-β and SSAO, as well as preclinical programs targeting proven pathways, such as GIP.
We invite you to read more about our company on our website at www.eccogene.com
Company Details
- Employees
- 25
- Founded
- -
- Address
- 255 Main St, Cambridge,massachusetts 02142,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- eccogene.com
- Keywords
- immune, metabolism, small molecule.
- HQ
- Cambridge, Massachusetts
Eccogene Questions
Eccogene's website is eccogene.com
Eccogene's LinkedIn profile is https://www.linkedin.com/company/eccogene
Eccogene has
25 employees.
View email and phone details for 25
employees at Eccogene.
Eccogene's industry is
Pharmaceutical Manufacturing
Eccogene's top competitors are
Alpha-9 Oncology,
Alladapt Immunotherapeutics, Inc.,
Astrazeneca,
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.,
Lifesci Consulting,
Haya Therapeutics,
Septerna,
Modifi Bio,
Carmot Therapeutics, Inc.,
Opus Genetics.
Eccogene's categories are Pharmaceutical Manufacturing
Eccogene's founding year is 2018
